MP
Therapeutic Areas
Base4 Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Neurology Program(s) | Neurodegenerative Diseases | Preclinical |
| Undisclosed Oncology Program(s) | Oncology | Preclinical |
| Undisclosed Neuromuscular Program(s) | Neuromuscular Disorders | Preclinical |
| Undisclosed Rare Disease Program(s) | Rare Diseases | Preclinical |